RANTES Gene Polymorphisms Associated with HIV-1 Infections in Kenyan Population

Dis Markers. 2016:2016:4703854. doi: 10.1155/2016/4703854. Epub 2016 Oct 16.

Abstract

Previous studies have reported that two single nucleotide polymorphisms (SNPs) in the RANTES gene promoter region, -403G/A and -28C/G, are associated with a slower rate of decline in CD4+ T cell count. In addition, as a ligand of the major HIV coreceptor CCR5, it is known to block HIV-CCR5 interactions in the course of the HIV infection cycle. This study was carried out with the aim of determining the occurrence of single nucleotide polymorphisms (SNPs) -403G > A and -28C > G in the promoter region of RANTES, in a subset of the Kenyan population. Genomic DNA was extracted from peripheral blood monocular cells and used to amplify the RANTES gene region. Restriction fragment length polymorphism was used to determine the genotypes of the RANTES gene. Out of 100 HIV infected individuals, 19% had G1 genotypes (403G/G, 28C/G), 30% (403A/A, 28C/C), and 50% (403G/A, 28C/C), while in healthy blood donors 13% had G4 (403G/A, 28C/C) genotypes, 22% (403A/A, 28C/C), and 54% (403G/A, 28C/C). HIV negative blood donors (54%) had higher risk of alteration to risk of HIV transmission compared to those who were HIV infected (50%). However, the risk to transmission and distribution differences was not significant (P = 0.092). The study showed that RANTES polymorphisms -403 and -28 alleles do exist in the Kenyan population.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Biomarkers / metabolism*
  • Case-Control Studies
  • Chemokine CCL5 / genetics*
  • Female
  • Follow-Up Studies
  • Genetic Predisposition to Disease
  • Genotype
  • HIV Infections / epidemiology*
  • HIV Infections / genetics*
  • HIV Infections / virology
  • HIV-1 / physiology*
  • Humans
  • Kenya / epidemiology
  • Male
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single Nucleotide / genetics*
  • Prognosis
  • Young Adult

Substances

  • Biomarkers
  • CCL5 protein, human
  • Chemokine CCL5